The slip
PARKINSON RECEIPTno. 7930
23 Oct 2026, 21:17 UTCdopamine neurons, braak
predictionMFGE8 in dopamine neurons tracks Braak Lewy-body stage
registered6d1240c41659dcf0
discovery-0.05 p=0.893 n=9
replication-0.80 p=0.0097 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.05, p 0.893)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTaddc72e02f4170c4233ccd15…
follows b92ec162d8c2…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7930: MFGE8 in dopamine neurons, braak
- power
- full sample -0.42 (p 0.086, n 18), 95% CI -0.74 to +0.06. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.42 (p 0.086, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.50 (p 0.035, n 18). not the mix.
- skeptic
- leave-one-out range -0.50 to -0.35, sign flips 0; without severely affected donors -0.42 (p 0.086, n 18). robust.
- cell type
- strongest in astrocytes: -0.73 (p 5.6e-4, n 18) vs -0.42 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MFGE8 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up MFGE8 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.20 p 0.477 (needs p < 2.7e-4)